Product IntroductionBioactivity英文名:
FTI-277 hydrochloride描述: FTI-277 hydrochloride (FTI 277 HCl) 是一种法尼基转移酶FTase 抑制剂,高效 Ras CAAX 肽模拟物,可抑制H-Ras 和K-Ras 信号转导,还可抑制hepatitis delta virus 感染。
细胞实验: Cells are seeded at 8000–14 000 cells/well in 96-well plates. To establish a dose–response to FTI-277, cells are incubated for 96 h in two-fold serial dilutions ranging from 3.75 times 10-7 M to 1 times 10-5 M. Following continuous drug exposure, 50 μL MTT dye is added. The insoluble formazan complex is solubilized with DMSO and absorbance measured at 540 nm. IC50s and 95% confidence intervals are calculated by regression analysis of the linear portion of the dose–response curve. (Only for Reference)
激酶实验: FTase and GGTase I Activity Assay: FTase and GGTase I activities from 60,000×g supernatants of human Burkitt lymphoma (Daudi) cells are assayed. Inhibition studies are performed by determining the ability of Ras CAAX peptidomimetics to inhibit the transfer of [3H]farnesyl and [3H]geranylgeranyl from [3H]farnesylpyrophosphate and [3H]geranylgeranylpyrophosphate to H-Ras-CVLS and H-Ras-CVLL, respectively.
体外活性: 在感染乙型肝炎病毒和丁型肝炎病毒的小鼠体内,FTI-277(50 mg/kg/day,i.p.)可有效清除丁型肝炎病毒血症.
体内活性: 在耐药骨髓瘤细胞中,FTI-277对细胞生长有抑制作用,还诱导细胞凋亡。在SH-SY5细胞中,FTI-277对细胞退化、活化、c-Jun-N端激酶级联和Ras激活过程中甲基苯丙胺诱导的毒性有减弱作用。FTI-277抑制Ras加工(IC50:100 nM),但对全细胞中四异戊二烯化Rap1A加工无影响。FTI-277导致辐射后细胞凋亡增加,并使H-ras转化的大鼠胚胎细胞的辐射敏感性增加。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : 12 mg/mL (24.8 mM)
H2O : 14 mg/mL (28.9 mM)
DMSO : 89 mg/mL (183.9 mM)
关键字:
Inhibitor |
Farnesyl Transferase |
FTI 277 |
Ras |
Ftase |
FTI-277 Hydrochloride |
FTI 277 Hydrochloride |
inhibit |
FTI277 Hydrochloride |
FTI-277 |
FTI277 hydrochloride |
Apoptosis |
FTI 277 hydrochloride |
FTI277相关产品:
Propylparaben |
UNC1215 |
Cl-amidine hydrochloride |
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil |
Flavokawain A |
OSI-930 |
Fangchinoline |
Sinapinic Acid |
Ligustrazine |
Isocurcumenol相关库:
Anti-Prostate Cancer Compound Library |
Anti-Cancer Metabolism Compound Library |
Membrane Protein-targeted Compound Library |
Bioactive Compounds Library Max |
GPCR Compound Library |
Kinase Inhibitor Library |
Inhibitor Library |
Anti-Cancer Active Compound Library |
Highly Selective Inhibitor Library |
Preclinical Compound Library